Deepak Gondaliya
Corporate Officer/Principal at Emcure Pharmaceuticals Ltd.
Deepak Gondaliya active positions
Companies | Position | Start | End |
---|---|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 30/06/2013 | - |
Career history of Deepak Gondaliya
Former positions of Deepak Gondaliya
Companies | Position | Start | End |
---|---|---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | - | - |
Training of Deepak Gondaliya
Hemchandracharya North Gujarat University | Doctorate Degree |
Statistics
International
India | 4 |
Operational
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
Private companies | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Stock Market
- Insiders
- Deepak Gondaliya
- Experience